CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
21.09
+14.22 (207.08%)
Jun 17, 2025, 12:34 PM - Market open

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5.23.251.520.481.1
Cash & Short-Term Investments
5.23.251.520.481.1
Cash Growth
13.29%113.76%219.73%-56.68%-
Prepaid Expenses
0.560.270.370.230.26
Restricted Cash
-0.070.0841.67-
Other Current Assets
-0.11---
Total Current Assets
5.773.711.9742.371.36
Property, Plant & Equipment
1.721.993.16--
Long-Term Deferred Tax Assets
----0.02
Long-Term Deferred Charges
0.50.5---
Other Long-Term Assets
----178.7
Total Assets
7.996.215.1342.37180.08
Accounts Payable
6.384.511.671.650.01
Accrued Expenses
0.471.910.1400.08
Short-Term Debt
--0.60.65-
Current Portion of Leases
0.910.880.77--
Current Income Taxes Payable
---0.6-
Other Current Liabilities
0.110.110.3227.84-
Total Current Liabilities
7.867.43.5130.750.1
Long-Term Leases
0.460.71.58--
Other Long-Term Liabilities
---22.62187.65
Total Liabilities
8.328.15.0853.37187.75
Common Stock
00000
Additional Paid-In Capital
73.3567.141.03--
Retained Earnings
-76.02-70.92-43.09-11-7.67
Comprehensive Income & Other
-0.08-1.3---
Total Common Equity
-2.76-5.07-42.06-11-7.67
Shareholders' Equity
-0.33-1.890.04-11-7.67
Total Liabilities & Equity
7.996.215.1342.37180.08
Total Debt
1.371.582.940.65-
Net Cash (Debt)
3.841.68-1.42-0.171.1
Net Cash Per Share
65.1465.70--15.48-
Filing Date Shares Outstanding
0.390.27-4.64.61
Total Common Shares Outstanding
0.260.12-4.64.61
Working Capital
-2.09-3.69-1.5411.621.26
Book Value Per Share
-10.67-41.98--2.39-1.67
Tangible Book Value
-2.76-5.07-42.06-11-7.67
Tangible Book Value Per Share
-10.67-41.98--2.39-1.67
Machinery
2.552.552.55--
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q